WHEREIN X IS SELECTED FROM THE GROUP CONSISTING OF METHYL AND ETHYL, R1 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS, R IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND UNSATURATED HYDROCARBON OF 2 TO 4 CARBON ATOMS, R2 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS, WHEN R IS HYDROGEN AND R2 IS WITH R3, WHEN OR2 AND OR3 HAVE THE SAME SPATIAL CONFIGURATION, AN ALKYLIDENE OR ARALKYLIDENE IN THE FORM OF
>C(-A)-B
WHEREIN A IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND HYDROCARBON AND B IS A HYDROCARBON AND R3 MAY ALSO BE SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS AND THE WAVY LINES MEAN THAT THE SUBSTITUENT MAY BE IN THE A OR B CONFIGURATION HAVING INTENSE UTEOTROPHIC AND ESTROGENIC ACTIVITY AND VERY INTENSE ANTIGONADOTROPHIC ACTIVITY AND THEIR PREPARATION.
WHEREIN R IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ALKALI METAL USEFUL AS ANTI-INFLAMMATORY AGENTS HAVING PROLONGED ACTIVITY AND THEIR PREPARATION.
WHEREIN R REPRESENTS ALKYL HAVING 1 YO 3 CARBON ATOMS AND THE -OH IN THE 16 POSITION IS SELECTED FROM THE GROUP CONSISTING OF THE A-OH AND THE B-OH; AS WELL AS PROCESS FOR THE PREPARATION OF THE COMPOUNDS, INTERMEDIATES IN THE PROCESS, THERAPEUTIC COMPOSITIONS CONTAINING THE COMPOUNDS AND THE METHOD OF PREVENTING PREGNACY IN WARM-BLOODED ANIMALS BY ADMINISTRATION OF THE COMPOUNDS.
Abstract:
WHEREIN R is alkyl having one to three carbon atoms, X represents a member selected from the group consisting of hydrogen, aliphatic hydrocarbon having one to six carbon atoms, halogenated aliphatic hydrocarbon having one to six carbon atoms, and cycloalkyl having three to six carbon atoms, Y is alkyl having one to six carbon atoms, Z represents a member selected from the group consisting of hydrogen, alkyl having one to six carbon atoms and phenyl alkyl having seven to nine carbon atoms, and R'' represents a member selected from the group consisting of hydrogen and the acyl of an organic carboxylic acid having from one to 18 carbon atoms; as well as a process for preparing the compounds, therapeutic compositions and methods. The 11 Alpha alkoxylated steroids possess anti-estrogenic, anti-gonadotrophic and exogenic anti-androgenic activity.
WHEREIN R AND X ARE ALKYL OF 1 TO 4 CARBON ATOMS, R1 IS A SATURATED OR UNSATURATED HYDROCARBON OF 1 TO 6 CARBON ATOMS, R2 IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS AND Y AND Y'' ARE SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND METHYL AND THE ENOLIC ESTERS THEREOF WITH AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS WHICH POSESS ANTI-ANDROGENIC AND ANTIESTROGENIC ACTIVITY, THEIR PREPARATION AND NOVEL INTERMEDIATES.
Abstract:
NOVEL 11B-LOWER ALKOXY-$1,3,5(10)-GONATRIENS SUBSTITUTED IN THE 3-POSITIONS BY A MEMBER SELECTED FROM THE GROUP CONSISTING OF HYDROXY, ALKOXY OF 1 TO 4 CARBON ATOMS, CYCLOALKOXY OF 5 TO 6 CARBOM ATOMS, AND ACYLOXY, WHEREIN THE ACYL IS DERIVED FROM AN ORGANIC CARBOXYLIC ACID HAVING 1 TO 10 CARBOM ATOMS, IN THE 13-POSITION BY A LOWER ALKYL RADICAL, AND IN THE 17-POSITION BY THE GROUPING
(X-O-),(Y--)
WHEREIN X IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ALKYL OF 1 TO 4 CARBON ATOMS, AND Y IS SELECTED FROM THE GROUP CONSISTING OF A HYDROCARBON RADICAL AND A SUBSTITUTED HYDROCARBON RADICAL. THESE COMPOUNDS POSSESS ESTROGENIC ACTIVITY.
Abstract:
Novel 7 Alpha -methyl-13 Beta -alkyl-18,19-dinor- Delta 4,9,11pregnatrienes of the formula
WHEREIN R is alkyl of one to three carbon atoms and R'' is selected from the group consisting of hydrogen, alkyl of one to three carbon atoms and OR'''' wherein R'''' is selected from the group consisting of hydrogen and acyl of an organic carboxylic acid of one to 18 carbon atoms having very intense antiandrogenic activity without manifesting antihypophysical properties with LH predominance to weak degree and to novel process and intermediates.
Abstract:
NOVEL 12B-ALKYL-$4.9-GONADIENES OF THE FORMULA
12-X,13-R,17-(R1=)-GONA-4,9-DIEN-3-ONE
AND 12-ALKYL:$4.9.11-GONATREIENES OF THE FORMULA
12-X,13-R,17-(R1=)-GONA-4,9,11-TRIEN-3-ONE
WHEREIN R IS ALKYL OF 1 TO 3 CARBON ATOMS, X IS ALKYL OF 1 TO 3 CARBON ATOMS AND R1 IS SELECTED FROM THE GROUP CONSISTING OF
(R2-O-),(H-); (R2-O-),(R3-); AND (HO-),(R3-)
WHEREIN R2 IS SELECTED FROM THE GROUP CONSISTING OF HYDROCARBYL OF 1 TO 10 CARBON ATOMS AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS AND R3 IS SELECTED FROM THE GROUP CONSISTING OF SATURATED HYDROCARBON OF 1 TO 6 CARBON ATOMS AND UNSATURATED HYDROCARBON OF 2 TO 6 CARBON ATOMS WHICH COMPOUNDS POSESS HORMONAL PROPERTIES AND TO TWO NOVEL PROCESSES FOR THEIR PREPARATION AND NOVEL INTERMEDIATES THEREFOR.
WHEREIN R IS ALKYL OF 1 TO 4 CARBON ATOMS AND R'' IS SELECTED FROM THE GROUP CONSISTING OF HYDROGEN AND ACYL OF AN ORGANIC CARBOXYLIC ACID OF 1 TO 18 CARBON ATOMS HAVING ANTI-OVULATORY ACTIVITY AND THEIR PREPARATON AND INTERMEDIATES THEREOF.